Concepedia

Author

Elisabetta Torlone

University of PerugiaORCID

Also Known As

E Torlone, E. Torlone, ELISABETTA TORLONE, Elisabetta Torlone, Francesco Dotta, J. A. Jansen, P. Bouter, S. Arnone, Torlone, E.

70

Publications

2.9K

Citations

27

H-Index

28

Concepts

All Affiliations

University of PerugiaUniversity of PaduaUniversity of Chieti-PescaraSapienza University of RomeAzienda ospedaliera "Bianchi-Melacrino-Morelli"
ET

About

Elisabetta Torlone is an author at University of Perugia specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

748

2

Diabetes

10

10

748

3

Health Sciences

6

6

473

4

Public Health

1

1

25

5

Cell Biology

1

1

115

Elisabetta Torlone

×

28

Publications

2.2K

Citations

24

H-Index

YearCitations

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial

Roel P.L.M. Hoogma, Peter Hammond, Ramón Gomis,

Diabetic Medicine

2005

253

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

C. Lalli, M. Ciofetta, Paola Sindaco,

Diabetes Care

1999

195

Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime

Paolo Rossetti, Simone Pampanelli, Carmine G. Fanelli,

Diabetes Care

2003

150

Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin

Francesca Porcellati, Paolo Rossetti, Simone Pampanelli,

Diabetic Medicine

2004

128

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

Elisabetta Torlone, Carmine G. Fanelli, A. M. Rambotti,

Diabetologia

1994

127

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes

Geremia B. Bolli, David Kerr, Reena Thomas,

Diabetes Care

2009

118

ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with Type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

Elisabetta Torlone, A. M. Rambotti, G. Perriello,

Diabetologia

1991

115

Demonstration of a role for growth hormone in glucose counterregulation

Pierpaolo De Feo, G. Perriello, Elisabetta Torlone,

American Journal of Physiology-Endocrinology and Metabolism

1989

115

Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal

Paola Sindaco, M. Ciofetta, C. Lalli,

Diabetic Medicine

1998

95

Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning

G. Perriello, Pierpaolo De Feo, Elisabetta Torlone,

Diabetologia

1990

89

Page 1